• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pediatrics

Parental nonmedical prescription opioid use linked to adolescent use

byMichael DinhandLeah Carr, MD
February 25, 2019
in Pediatrics, Psychiatry, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Nonmedical prescription opioids (NMPO) use in parents is an independent risk factor for use in their adolescent children, even after controlling for other substance use and sociodemographic factors.

2. Additional parental risk factors for adolescent NMPO use were parental smoking, low levels of monitoring, and high levels of parent-adolescent conflict.

Evidence Rating Level: 4 (Below Average)

Study Rundown: Parental use of tobacco, alcohol, marijuana, and other substances has been shown to be an independent risk factor for adolescent substance use. Despite these prior findings, potential intergenerational NMPO use between parents and children has not yet been examined, even though many adolescents identify family members as a source of NMPOs. In this cross-sectional study, researchers used survey data from the National Survey on Drug Use and Health (NSDUH) of parent-adolescent dyads to examine the association between parental and adolescent NMPO use. After controlling for other drug use and sociodemographic characteristics, parental, specifically maternal, NMPO was significantly associated with adolescent use. Additional parental risk factors for adolescent NMPO use were parental smoking, low levels of monitoring, and high levels of parent-adolescent conflict. Adolescent risk factors for NMPO use included cigarette or marijuana use, being depressed, and perceiving that most schoolmates used drugs; protective factors were believing that drug use was risky and high religiosity.

These findings are limited by the focus on lifetime use, rather than more specific use patterns. Furthermore, the data were cross-sectional and used only parent-adolescent dyads, not triads. Nonetheless, the study is strengthened by its large, nationally-representative sample and novel exploration of a previously unexamined association. For physicians, these findings highlight the importance of addressing parental NMPO use as a risk factor for adolescent use, potentially by screening for affected adolescents and parents and offering interventions for both.

Click to read the study, published today in Pediatrics

Relevant reading: Characterizing Adolescent Prescription Misusers: A Population-Based Study

RELATED REPORTS

Testing for sexually transmitted infections is infrequent among high school students in the United States

Barriers to medication access for opioid use disorder in adolescents and young adults

mRNA Covid-19 vaccine remained safe and efficacious through 6 months

In-Depth [cross-sectional study]: Researchers used cross-sectional survey data from the 2004-2012 NSDUH to identify 35 000 parent-adolescent dyads with an adolescent aged 12 to 17 years. The study estimated the association between parent and adolescent self-reported lifetime NMPO use while controlling for parent and adolescent other drug use, attitudes about drug use, and sociodemographic characteristics.

There was a significant association between parent and adolescent NMPO use; 13.9% of adolescents whose parents had used an NMPO also did so, compared with 8.1% when a parent had not used (adjusted odds ratio [aOR] 1.30; 95% CI 1.09-1.56). Only maternal, and not paternal, NMPO use was significantly associated with adolescent NMPO use (aOR 1.62; 95% CI 1.28-2.05) and did not differ by child sex or parent-adolescent race. When controlling for parental use of other drugs, lifetime smoking retained a positive association with adolescent NMPO use (aOR 1.24; 95% CI 1.02-1.51). Adolescent risk factors included cigarette or marijuana use before NMPO, being depressed (aOR 1.62; 95% CI 1.37-1.93), and perceiving that most schoolmates used drugs (aOR 1.71; 95% CI 1.44-2.04). Adolescent protective factors for NMPO use were believing that drug use was risky (aOR 0.77; 95% CI 0.72-0.82) and high religiosity (aOR 0.92; 95% CI 0.86-0.99).

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: adolescent medicinenonmedical prescription opioid use (NPOU)
Previous Post

Quick Take: Assessment of Trends in Transplantation of Liver Grafts From Older Donors and Outcomes in Recipients of Liver Grafts From Older Donors, 2003-2016

Next Post

Early intensive treatment of multiple sclerosis associated with slower progression of disability

RelatedReports

AAP opposes school-based drug testing of adolescents
Chronic Disease

Testing for sexually transmitted infections is infrequent among high school students in the United States

April 11, 2022
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Chronic Disease

Barriers to medication access for opioid use disorder in adolescents and young adults

April 4, 2022
Novel coronavirus identified from patients with pneumonia in Wuhan, China
Chronic Disease

mRNA Covid-19 vaccine remained safe and efficacious through 6 months

January 26, 2022
Social networks play key roles in parental vaccination decisions
Chronic Disease

Drug overdose an important cause of death amongst people experiencing homelessness

January 11, 2022
Next Post
Asymptomatic women at high risk for Multiple Sclerosis may have early subclinical neuroimaging abnormalities

Early intensive treatment of multiple sclerosis associated with slower progression of disability

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial

Overlapping surgery not associated with adverse patient outcomes

Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease

Genetic variants in NUDT15 associated with increased risk of thiopurine-induced myelosuppression

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.